Ameet Sarpatwari
Harvard University
H-index: 26
North America-United States
Top articles of Ameet Sarpatwari
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Estimated Medicare Part D Savings From Generic Drugs With a Skinny Label | Annals of Internal Medicine | Alexander C Egilman Aaron S Kesselheim Ameet Sarpatwari Benjamin N Rome | 2024/4/30 |
Patents on Risk Evaluation and Mitigation Strategies for Prescription Drugs and Generic Competition | JAMA | Ameet Sarpatwari Sajeev Kohli S Sean Tu Aaron S Kesselheim | 2024/2/22 |
How Do Risk Evaluation and Mitigation Strategies Impact Clinical Practice? A National Survey of Physicians | Clinical Pharmacology & Therapeutics | Ameet Sarpatwari Zhigang Lu Massimiliano Russo Heidi Zakoul Su Been Lee | 2024/2/20 |
Independent Advice on Drug Approvals: an Investigation of EMA Practices | Journal of General Internal Medicine | C Joseph Ross Daval Aaron S Kesselheim Leigh Sharpless Ameet Sarpatwari | 2024/2 |
Improving Drug Supply Chain Security | JAMA Health Forum | Joseph T Kannarkat Michael W Denham Ameet Sarpatwari | 2024/1/5 |
Frequency of Approval and Marketing of Biosimilars With a Skinny Label and Associated Medicare Savings | JAMA Internal Medicine | Alexander C Egilman Victor L Van de Wiele Benjamin N Rome Jonathan J Darrow S Sean Tu | 2023/1/1 |
Physician experiences with and perceptions of risk evaluation and mitigation strategy programs with elements to assure safe use | Plos one | Ameet Sarpatwari Beatrice L Brown Sarah A McGraw Sara Z Dejene Abdurrahman Abdurrob | 2023/7/6 |
Public Returns on Public Investment: Moderna’s Violation of the Social Contract | Journal of Law, Medicine & Ethics | Ameet Sarpatwari | 2023/12 |
HPR115 Patient and Provider Factors Associated with Filgrastim Biosimilar Uptake in the US | D Hong AS Kesselheim A Sarpatwari B Rome | 2023/6/1 | |
INTRODUCTION: Promoting Drug and Vaccine Innovation and Managing High Prices: Introducing a Special Symposium | Journal of Law, Medicine & Ethics | Aaron Kesselheim Ameet Sarpatwari Benjamin Rome | 2023/12 |
Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures | Plos Medicine | Beatrice L Brown Aaron S Kesselheim Ameet Sarpatwari | 2023/3/6 |
Outcomes of the 340B Drug Pricing Program: A Scoping Review | Ryan P Knox Junyi Wang William B Feldman Aaron S Kesselheim Ameet Sarpatwari | 2023/11/3 | |
US public investment in development of mRNA covid-19 vaccines: retrospective cohort study | bmj | Hussain S Lalani Sarosh Nagar Ameet Sarpatwari Rachel E Barenie Jerry Avorn | 2023/3/1 |
Changes in Induced Medical and Procedural Abortion Rates in a Commercially Insured Population, 2018 to 2022: An Interrupted Time-Series Analysis | Annals of Internal Medicine | Catherine S Hwang Aaron S Kesselheim Ameet Sarpatwari Krista F Huybrechts Gregory Brill | 2023/11 |
A" Method of Use" to Prevent Generic and Biosimilar Market Entry | The New England journal of medicine | S Sean Tu Ameet Sarpatwari | 2023/2/9 |
The 340B Drug Pricing Program: Litigation, Administration, and Reform | Oklahoma Law Review, Forthcoming | Ryan Knox Ameet Sarpatwari | 2023/9/5 |
Hydroxyzine initiation following drug safety advisories on Cardiac Arrhythmias in the UK and Canada: a longitudinal cohort study | Drug safety | Richard L Morrow Barbara Mintzes Patrick C Souverein Christine E Hallgreen Bilal Ahmed | 2022/6 |
Inflation Reduction Act and US drug pricing | Ameet Sarpatwari | 2022/9/8 | |
COVID-19 antivirals must not affect HIV drug supply | The Lancet HIV | Melissa Barber Ameet Sarpatwari Christa Cepuch | 2022/1/1 |
Civil commitment for opioid misuse: do short-term benefits outweigh long-term harms? | Journal of medical ethics | John C Messinger Daniel J Ikeda Ameet Sarpatwari | 2022/9/1 |
Co-Authors
